Cargando…
Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer
Background: We obtained 2 types of clones which were termed SC (sphere-shaped clone) and NSC (non-sphere-shaped clone) from 4T1 cells by monoclonal culture. SC and NSC were distinct in morphology, surface marker, metabolism and proliferation rate. With the transcriptome sequencing data analysis, we...
Autores principales: | Lin, Xia, Liu, Jian, Hu, Shu Fang, Hu, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497492/ https://www.ncbi.nlm.nih.gov/pubmed/31114314 http://dx.doi.org/10.2147/CMAR.S192949 |
Ejemplares similares
-
Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer
por: Fang, Zheng, et al.
Publicado: (2022) -
TMED2 as a marker of prognosis in breast cancer [Letter]
por: Schwarz, Megan Catherine, et al.
Publicado: (2019) -
Expression and Importance of TMED2 in Multiple Myeloma Cells
por: Ge, Xueling, et al.
Publicado: (2020) -
The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10
por: Yang, Xue, et al.
Publicado: (2020) -
TMED2 promotes epithelial ovarian cancer growth
por: Shi-Peng, Gong, et al.
Publicado: (2017)